EV BIOLOGICS
EV Biologics, Inc. is a biotechnology company focused on innovation in engineered exosome-based therapeutic development to create next-generation biopharmaceuticals with targeted delivery of bioactive molecules to specific cells and tissues involved in disease and injury. Our exosome design, engineering and research systems aim to leverage technology to optimize biological drug discovery, scalable GMP biomanufacturing, preclinical development and clinical trials to rapidly bring safe, effective, FDA-approved biopharmaceuticals into practice.
EV BIOLOGICS
Industry:
Biopharma Biotechnology
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.evbiologics.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Apps For Business
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Essent Biologics
Essent Biologics is a nonprofit biotechnology company.
Genosco
Genosco is a biotechnology company.
VisualSonics
VisualSonics is a Biotechnology company.
Current Employees Featured
Founder
Official Site Inspections
http://www.evbiologics.com
- Host name: 172.67.202.129
- IP address: 172.67.202.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "EV Biologics"
About Us | EV Biologics
With a focus on advancements in medical diagnostics and therapeutics through EV research and development, EV Biologics is building a world-class team of molecular biologists, analytical biochemists, nanoparticle biophysicists, โฆSee details»
EV Biologics - Crunchbase Company Profile & Funding
Contact Email [email protected] EV Biologics, Inc. is a biotechnology company focused on innovation in engineered exosome-based therapeutic โฆSee details»
EV Biologics - LinkedIn
EV Biologics | 103 followers on LinkedIn. Exosome biotechnology, bioinformatics, bioengineering, biomanufacturing & biopharmaceuticalsSee details»
EV Biologics, Inc. (YECO)
Find the latest EV Biologics, Inc. (YECO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
EV Biologics Company Profile 2025: Stock Performance & Earnings โฆ
EV Biologics General Information Description. EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic โฆSee details»
Home - EvoBio
Evolutionary Biologics offers up a range of cellular breakthrough products for Hair Restoration, Skin Rejuvenation, and a lineup for the Body: Including Orthobiologics, Neurobiolgics, Sexual โฆSee details»
EV Biologics - SPEEDA Edge
EV Biologics is a biotechnology company focused on developing therapeutic products based on extracellular vesicles (EVs), particularly exosomes. The company specializes in the production โฆSee details»
EV Biologics
Bioactivity of some types of EVs such as exosomes enables the development of novel therapeutic agents. As an example, exosomes produced by mesenchymal stem cells (MSCs) have โฆSee details»
EV Biologics Confirms Funding to Commence Cell Line ... - BioSpace
Apr 8, 2021 NASHVILLE, TN / ACCESSWIRE / April 8, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director's loan agreement to secure โฆSee details»
Business | EV Biologics
From biotechnology to business development, EV Biologics is focused on innovation. Driven by advanced analytics for scientific, clinical and market data, our objective is to optimize โฆSee details»
SCIENCE - EV Biologics
With a focus on advancements in medical diagnostics and therapeutics through EV research and development, EV Biologics is building a world-class team of molecular biologists, analytical โฆSee details»
EVBiome
EVBiome's site. Our mission is to convert the potential of extracellular vesicles into more accessible and effective diagnostic and treatment solutions to support patients and physicians.See details»
EV Biologics Corp. - June 30, 2023 Quarterly Report-final updated
Www.evbiologics.com [email protected] SIC Code: 8731 Quarterly Report For the Period Ending June 30, 2023 (the โReporting Periodโ) Outstanding Shares: The number of โฆSee details»
EV Biologics Designs Process for Scalable Exosome โฆ
Feb 22, 2021 EV Biologics Corp. EV Biologics (formerly Yulong Eco-Materials Limited) is a Wyoming, USA domiciled Biotechnology Company based in Nashville, TN, intent on bringing โฆSee details»
About - EvoBio
Dr. Melinda Lacerna is a Double Board-Certified Plastic Surgeon from Bradenton, Florida, USA. She went to medical school at the University of California, Irvine College of Medicine, โฆSee details»
EV Biologics Designs Process for Scalable Exosome โฆ
NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has โฆSee details»
EV Biologics Designs Process for Scalable Exosome ... - Nasdaq
Feb 22, 2021 NASHVILLE, TN/ ACCESSWIRE/ February 22, 2021/ EV Biologics Corp,, today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a โฆSee details»
EV Biologics Launches Excyte with $100 million Valuation
Aug 15, 2022 EV Biologics Corp, OTC Pink: YECO, today announced that it has launched Excyte, Inc., a wholly owned subsidiary, with $100 Million valuation. Excyte has already raised โฆSee details»
Characterization of extracellular vesicle-associated DNA and โฆ
May 23, 2025 Gene ontology scanning of these proteins displayed the presence of many factors having metastatic-inducing potentials and that clustered in categories related to hallmark of โฆSee details»
Medicine - EV Biologics
Urine or saliva will provide clinical researchers with the means to perform liquid biopsies that avoid the morbidity of surgical biopsy. Future EV-based diagnostics will facilitate early detection and โฆSee details»